Select Page

Dermal regeneration platform uses 3D bioprinting

Dermal regeneration platform uses 3D bioprinting

Written by David

February 27, 2019

ROKIT Healthcare Inc, a regenerative medicine company focused on the development of novel regenerative therapeutic strategies using three-dimensional (3D) biofabrication technologies for treatment of various medical conditions including dermatological, orthopedic, and autoimmune disorders, announced a novel application of dermal regeneration platform using autologous cells and its proprietary 3D bioprinter INVIVO®. This new regenerative therapeutic platform will be further studied in clinical settings for patients in need of treatment for damages suffered from dermal scarring. For more information see the IDTechEx report on 3D Bioprinting 2018-2028 . Skin scarring is one of the most common medical conditions that can arise after almost every dermal injury, some of which can cause considerable physical, aesthetic, psychological and social problems that result in millions of elective operations and operations after trauma. ROKIT’s treatment strategy uses INVIVO®, ROKIT’s proprietary 3D bioprinter, and patient’s autologous tissues and cells to “print” a dermal patch graft to […]


Submit a Comment

Your email address will not be published. Required fields are marked *

You May Also Like…

Pin It on Pinterest

Share This

Share this post with your friends!